Effects of Video Animation-Assisted Inhaler Medication Education on Medication Adherence, Attack Frequency, and Dyspnea for Asthma Patients
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Gaziantep, Turkey, 27000
- Gaziantep Üniversitesi
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Patients who are:
- 18 years of age or older,
- Diagnosed with asthma for at least 6 months,
- Using at least one inhaler,
- No communication problems that would prevent them from participating in the study or receiving training,
- Literate,
- Have internet access at home or on their phone,
- Own and use a computer, tablet, or smartphone,
- Voluntarily agree to participate in the study
Exclusion Criteria:
Individuals who:
- Do not meet the inclusion criteria,
- Are unwilling to participate in the study,
- Do not own a computer, tablet, or smartphone,
- Have a psychiatric illness
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control group
The control group will not receive training.
The evaluation form will be administered simultaneously with the intervention group.
At the end of the study, the patient will be shown the video once if they wish.
|
|
|
Experimental: INTERVENTION GROUP
Patients in the intervention group will watch an educational video at the beginning of the study, on the 15th day, and at the 4th week.
|
The training is presented not verbally but with the prepared "Video Animation Support"
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Video animation-assisted inhaler drug education has effects on drug compliance, attack frequency and dyspnea.
Time Frame: Each patient will be followed up for 30 days.
|
Data were collected using a questionnaire, the mMRC Shortness of Breath Scale, the Asthma Control Test (ACT), and the Inhaler Compliance Scale.
The mMRC Shortness of Breath Scale is a 5-point scale (0-4).
A higher score indicates greater severity of dyspnea.
The Asthma Control Test (ACT) is a 25-point scale.
A higher score is considered good control.
The Inhaler Compliance Scale is a 30-point scale.
A higher score indicates good inhaler compliance.
The mMRC Shortness of Breath Scale, the Asthma Control Test (ACT), and the Inhaler Compliance Scale were administered to both groups at the beginning of the study and at the end of the fourth week.
After 3 sessions of training, the decrease in the mMRC Shortness of Breath Scale mean score and the increase in the Asthma Control Test (ACT) and Inhaler Compliance Scale mean score indicate that the training was effective.
Student t, chi-square, Mann Whitney U and Kruskal Wallis tests were used to evaluate the data.
|
Each patient will be followed up for 30 days.
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- GAZİANTEP UN
- Seda İlgün (Registry Identifier: Gaziantep University Health Sciences Institute Internal Medicine Nursing)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.